Shen YJ, Zhang Y, Chang J, Wang HF, et al. CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease. Ann Hematol 2023;102:1731-1738.
PMID: 37145324